These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 21901908)

  • 1. Glomerular injury induced in mice by intraperitoneal injection of Shiga-like toxins.
    Koshi R; Pulimood AB; Date A; Kang G; Acheson D; Mathan MM
    Indian J Med Res; 2001 Feb; 113():63-9. PubMed ID: 21901908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
    Wen SX; Teel LD; Judge NA; O'Brien AD
    Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoprotective effect of curcumin in human proximal tubule epithelial cells exposed to shiga toxin.
    Sood A; Mathew R; Trachtman H
    Biochem Biophys Res Commun; 2001 Apr; 283(1):36-41. PubMed ID: 11322764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis.
    Flagler MJ; Strasser JE; Chalk CL; Weiss AA
    Infect Immun; 2007 Feb; 75(2):760-5. PubMed ID: 17101648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lepirudin prevents lethal effects of Shiga toxin in a canine model.
    Raife T; Friedman KD; Fenwick B
    Thromb Haemost; 2004 Aug; 92(2):387-93. PubMed ID: 15269836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
    Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
    Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of gamma interferon and tumor necrosis factor-alpha in shiga toxin lethality.
    Sasaki S; Omoe K; Tagawa Yi; Iwakura Y; Sekikawa K; Shinagawa K; Nakane A
    Microb Pathog; 2002 Jul; 33(1):43-7. PubMed ID: 12127799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga-toxin-induced firm adhesion of human leukocytes to endothelium is in part mediated by heparan sulfate.
    Geelen J; Valsecchi F; van der Velden T; van den Heuvel L; Monnens L; Morigi M
    Nephrol Dial Transplant; 2008 Oct; 23(10):3091-5. PubMed ID: 18469308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage.
    Lentz EK; Cherla RP; Jaspers V; Weeks BR; Tesh VL
    Infect Immun; 2010 Sep; 78(9):3689-99. PubMed ID: 20605983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli.
    Stearns-Kurosawa DJ; Collins V; Freeman S; Tesh VL; Kurosawa S
    Infect Immun; 2010 Jun; 78(6):2497-504. PubMed ID: 20308301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.
    Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M
    Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of Shiga toxin 1 in the central nervous system of rabbits.
    Fujii J; Kinoshita Y; Yutsudo T; Taniguchi H; Obrig T; Yoshida SI
    Infect Immun; 2001 Oct; 69(10):6545-8. PubMed ID: 11553604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of vascular endothelial growth factor and angiopoietin 1 in renal injury in hemolytic uremic syndrome.
    Ohara S; Kawasaki Y; Abe Y; Watanabe M; Ono A; Suyama K; Hashimoto K; Honda T; Suzuki J; Hosoya M
    Am J Nephrol; 2012; 36(6):516-23. PubMed ID: 23171542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of Shiga toxin-producing Escherichia coli (STEC) isolated from seafood and beef.
    Kumar HS; Karunasagar I; Karunasagar I; Teizou T; Shima K; Yamasaki S
    FEMS Microbiol Lett; 2004 Apr; 233(1):173-8. PubMed ID: 15043885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly and stability of the shiga toxins investigated by electrospray ionization mass spectrometry.
    Kitova EN; Mulvey GL; Dingle T; Sinelnikov I; Wee S; Griener TP; Armstrong GD; Klassen JS
    Biochemistry; 2009 Jun; 48(23):5365-74. PubMed ID: 19400587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
    Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
    Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a novel bioluminescent reporter system for investigating Shiga toxin expression of enterohemorrhagic Escherichia coli.
    Shimizu T; Ohta Y; Tsutsuki H; Noda M
    Gene; 2011 Jun; 478(1-2):1-10. PubMed ID: 21262333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinities of Shiga toxins 1 and 2 for univalent and oligovalent Pk-trisaccharide analogs measured by electrospray ionization mass spectrometry.
    Kitova EN; Kitov PI; Paszkiewicz E; Kim J; Mulvey GL; Armstrong GD; Bundle DR; Klassen JS
    Glycobiology; 2007 Oct; 17(10):1127-37. PubMed ID: 17686801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of rabbit polyclonal sera against Shiga toxins Stx1 and Stx2 for detection of Shiga toxin-producing Escherichia coli.
    Mendes-Ledesma MR; Rocha LB; Bueris V; Krause G; Beutin L; Franzolin MR; Trabulsi LR; Elias WP; Piazza RM
    Microbiol Immunol; 2008 Oct; 52(10):484-91. PubMed ID: 18822082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.